Africa-Press – Tanzania. OFFICIALS from Tanzania Medicines and Medical Devices Authority (TMDA) held a meeting with medical stakeholders to discuss and review the implementation of a project aimed at increasing health personnel efficiency in clinical trials.
Tanzania Medicines and Medical Devices Authority (TMDA) Director General Adam Fimbo said the project dubbed ASCEND is aimed at improving systems for Tanzania’s clinical research ethics and medicines regulatory capacity to monitor and regulate medical researches and trials in the country.
The meeting involved the implementing partners from several institutions to review how far the project has been implemented as part of strengthening regulatory and ethical reviews.
He made the remarks dur- ing the Ascend Project Annual Stakeholders meeting held in Dar es Salam recently.
The project worth Euro 498, 750 is currently 15 months old and is expected to end on April 30, 2023.
He explained that it will increase efficiency and quality review and inspection of clini- cal trials conducted in Tanzania and community awareness on research ethics. Mr Fimbo mentioned the ASCEND Consortium members who participated including TMDA, National Institute for Medical Research (NIMR), Zanzibar Health Research Institute (ZAHRI), Kilimanjaro Clinical Research Institute (KCRI), Muhimbili University of Health and Allied Sciences ( MUHAS) and Zanzibar Food and Drugs Authority (ZFDA).
He noted that the pro- gramme will build more capac- ity for TMDA to speed up reviews and issuance of approv- als for clinical trials.
ZAHRI’s Director of Research, Coordination and Promotion, Dr Ame Masemo said as part of stakeholders in implementing the project, it will continue strengthening regulatory and ethical reviews, including linking participating institutions.
He explained that the project would also build capacity among the local researchers, medical professionals and students as well as institutions to come up with better research outcomes.
Dr Masemo commented that it will also promote adoption and implementation of harmonized guidelines in clinical trials and support training institutions to provide both innovative and mentorship training to the National Ethics Committees and National Regulatory Authorities.
For More News And Analysis About Tanzania Follow Africa-Press
